INS and schizophrenia: The possible pathogenic relevance of our findings is supported by recent studies showing that abnormal insulin secretion and response [44-47] and abnormal glucose tolerance and risk of diabetes [48] are found already in drug-naïve first-episode patients with schizophrenia.